Business Market R...
Follow
Find
3.2K views | +0 today
 
Scooped by rnrmarketresearch
onto Business Market Research Reports
Scoop.it!

Global Tire Market Research Report 2011-2015

Global Tire Market Research Report 2011-2015 | Business Market Research Reports | Scoop.it

TechNavio’s analysts forecast the Global Tire market to grow at a CAGR of 5.01 percent over the period 2011-2015. One of the key factors for this growth is the growing Global Motorcycle market. The Global Tire market has also been witnessing the growing Global Automotive Tire market, which includes light, medium and heavy vehicles during forecast period. However, the increasing cost of raw materials and commodity products are acting as a barrier to the growth.

Get your copy of this report @ http://www.rnrmarketresearch.com/global-tire-market-2011-2015-market-report.html

TechNavio’s research report, the Global Tire Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the APAC, the North America, Western Europe, Eastern Europe, Africa and the Middle East, and the Central and South America regions. It also covers the Global Tire market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The scope of this report includes the entire range of tires for light vehicles, medium and heavy vehicles, industrial vehicles and others except retreaded and used tires available in the Global Tire market.

Key vendors dominating this market space include Bridgestone Corp., Compagnie Generale des Etablissements Michelin SCA, The Goodyear Tire and Rubber Co., and Continental AG.

Other vendors mentioned in the report: Pirelli and C. SpA, Sumitomo Rubber Industries Ltd., Yokohama Rubber Co. Ltd., Hankook Tire Co. Ltd., Cooper Tire and Rubber Co., Cheng-Shin Rubber Industries Co. Ltd., and HangZhou ZhongCe Rubber Co. Ltd.

Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.

more...
No comment yet.
Your new post is loading...
Your new post is loading...
Scooped by rnrmarketresearch
Scoop.it!

Water Treatment Chemicals Market worth 15.3 Million Lbs Consumption by 2018

RnRMarketResearch.com adds report “Water Treatment Chemicals Market By Type (Coagulants & Flocculants, Corrosion Inhibitor, Scale Inhibitors, Biocides, Chelating Agents, Anti-foaming Agents, pH Adjusters & Others) & Application (Industrial & Municipal) – Global Trends & Forecasts to 2018” to its store.

 

Company Profiles:-

 

Air Products & Chemicals Inc.Akzonobel N.V.Ashland Inc.Basf SeBuckman Laboratories International Inc.Bwa Water Additives Uk LimitedCarus CorporationChemtreat Inc.Cortec CorporationEcolab Inc.(Nalco Company)Feralco ABGe Water & Process TechnologiesKemira OyjKurita Water Industries Ltd.Lonza Group Ltd.Nippon Rensui Co.Plymouth Technology Inc.Snf GroupThe Dow Chemical CompanyThermax Ltd.Veolia Water Solutions & TechnologiesWujin Fine Chemical Factory Co. Ltd.

 

Complete report available @ http://www.rnrmarketresearch.com/water-treatment-chemicals-market-by-type-coagulants-flocculants-corrosion-inhibitor-scale-inhibitors-biocides-chelating-agents-anti-foaming-agents-ph-adjusters-others-application-indust-market-report.html .

 

Water treatment chemicals are primarily used for removing impurities from drinking as well as industrial water and wastewater. With the increasing scarcity of water resources globally, recycling and reuse of water has become very important. Water treatment chemicals are used effectively to remove harmful substances from water.

 

Key chemicals that are used in the water treatment include corrosion inhibitors, scale inhibitors, coagulants & flocculants, biocides & disinfectants, chelating agents, anti-foaming agents, ph adjusters & stabilizers, and others. Coagulants & flocculants are the most commonly used water treatment chemicals. However, scale and corrosion inhibitors together represent the significant market share in terms of value. Biocides and disinfectants also represent more than 10% of the value market, and are expected to grow at a decent pace. However, increasing regulations against the use of chemicals in water treatment is one of the key restraints in the industry.

 

Water treatment chemicals are used in industries such as power generation, food & beverage, chemical processing, pulp & paper, oil & gas, metal & mining, and others. Power generation is the important industrial application area for water treatment chemicals. Municipal water treatment represents around 35% of the total consumption of water treatment chemicals globally.

 

Geographically, Asia-Pacific is the key market for water treatment chemicals. It represents more than 35% of the market in terms of consumption. Rising demand for clean water in China and India is driving the Asia-Pacific as well as the global market for water treatment chemicals. China is the largest consumer for water treatment chemicals in the world.

 

Request a sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=153232 .

(This is a premium report priced at US$4650 for a single user PDF.)

 

Scope Of The Report

 

The global water treatment chemicals market is profoundly analyzed in terms of revenue ($million) and volume (million pounds).

 

By Applications

 

Industrial

 

Power generationFood & beverageChemical processingPulp & paperOil & gasMetal & miningOthers

 

Municipal

 

By Geography

 

Asia-PacificEuropeNorth AmericaRest of the World

 

By Types

 

Corrosion inhibitorScale inhibitorCoagulants & flocculantsBiocides & disinfectantsChelating agentsAnti-foaming agentspH adjusters & stabilizersOthers

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=153232 .

 

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Biopower Market (Biogas & Biomass) Technology Review, Competitive Landscape and Key Country Analysis to 2020 in a New Report Available at MarketOptimizer.org - WMBB News 13 - The Panhandle's...

Global Biopower Market (Biogas & Biomass) Technology Review, Competitive Landscape and Key Country Analysis to 2020 in a New Report Available at MarketOptimizer.org - WMBB News 13 - The Panhandle's... | Business Market Research Reports | Scoop.it
Biopower Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020, the latest report from industry analysis specialist offers comprehensive information and analysis of the global biopower market.
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Biopower Market (Biogas & Biomass) Technology Review, Competitive Landscape and Key Country Analysis to 2020 in a New Report Available at MarketOptimizer.org - Valley News Live - KVLY/KXJB -...

Global Biopower Market (Biogas & Biomass) Technology Review, Competitive Landscape and Key Country Analysis to 2020 in a New Report Available at MarketOptimizer.org - Valley News Live - KVLY/KXJB -... | Business Market Research Reports | Scoop.it
MarketOptimizer.org adds Biopower Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020 to its store. The report provides a clear overview of and detailed insight into the global biopower market.
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

SOCO International plc, Company Intelligence Report - RnR Market Research

SOCO International plc, Company Intelligence Report: Order report by calling marketoptimizer.org at +1 888 391 5441 OR send an email...
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Imidazole Industry (CAS 288-32-4) 2009-2019 for Global and China... - RnR Market Research

Market Research Report on Global and Chinese Imidazole Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Imidazole...
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Biopower Market Review and Outlook to 2020 | Teckler

Global Biopower Market Review and Outlook to 2020 | Teckler | Business Market Research Reports | Scoop.it
Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020: Order report by calling marketoptimizer.org at +
rnrmarketresearch's insight:

Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020: Order report by calling marketoptimizer.org at +1 888 391 5441 OR send an email on sales@marketoptimizer.org  with Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020 in subject line and your contact details.

“Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020”, the latest report from industry analysis specialist GlobalData, offers comprehensive information and analysis of the global biopower market.

The report provides a clear overview of and detailed insight into the global biopower market. It explains the key drivers and challenges affecting the market and also provides data regarding historic and forecast market growth, average capital expenditure, market size and regulations, globally and in the key biopower countries: US, Brazil, UK, Germany, India, and China.

The report uses data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GlobalData’s team of industry experts.

Scope

Detailed historic and forecast statistics for annual biomass and biogas installations from 2006 to 2025, both globally and for each of the key countriesReview of technology and cost.Coverage of the key growth drivers and challenges related to the global biopower marketCoverage of key countries in the biopower market and details of the share of biopower installations held by eachExplanation of the policies and regulations related to biopower in each of the key countries, and their impact on the market.

 

 Complete report available at http://www.marketoptimizer.org/biopower-global-market-size-technology-review-competitive-landscape-and-key-country-analysis-to-2020.html

Reasons To Buy

Facilitate decision-making based on strong historic and forecast data for the biopower marketMaximize potential in the growth of the biopower marketIdentify key partners and business-development avenuesRespond to competitors’ business structure, strategy and prospects

Table of Contents For This Report

1 Table of Contents 2

2 Executive Summary 11

3 Introduction 14

4 BioPower Market, Global 20

5 BioPower Market, US 40

6 BioPower Market, Brazil 65

7 BioPower Market, UK 79

8 BioPower Market, Germany 92

9 BioPower Market, India 10

10 BioPower Market, China 120

11 Appendix 133

Inquire for discount  @ http://www.marketoptimizer.org/contacts/discount?rname=9942 . (Report price: Single user license- US$ 3995 )

List of Tables

Table 1: Biopower Market, Primary Energy Conversion and Recovery Technologies, Comparison 15

Table 2: Biopower Market, Primary Energy Conversion and Recovery Technologies, Future Developments 18

Table 3: BioPower Market, Global, Cumulative Installed Capacity, GW, 2006–2025 22

Table 4: BioPower Market, Global, Annual Installed Capacity, GW, 2006–2025 24

Table 5: BioPower Market, Global, Annual Installed Capacity Split by country (%), 2013 26

Table 6: BioPower Market, Global, Cumulative Capacity by Feedstock, 2014 & 2019 28

Table 7: BioPower Market, North America, Cumulative Capacity by Feedstock, 2014 & 2019 29

Table 8: BioPower Market, Global, Cumulative Capacity by Feedstock, 2014 31

Table 9: BioPower Market, Global, Cumulative Capacity by Feedstock, 2014 32

Table 10: BioPower Market, Global, Electricity Generation, TWh, 2006–2025 34

Table 11: BioPower Market, Global, Average Capital Expenditure ($/kW), 2011–2025 36

Table 12: BioPower Market, Global, Investment ($bn), 2011–2025 38

Table 13: BioPower Market, US, Cumulative Installed Capacity, GW, 2006–2025 42

Buy a Copy of Report @ http://www.marketoptimizer.org/contacts/purchase?rname=9942 .

Contact sales@marketoptimizer.org   / Call +1 888 391 5441 for further information on “Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020” report OR for any other market research and intelligence needs you may have for your business.

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Overview of North America Energy Devices & Aesthetic Lasers Market to 2020

MarketOptimizer.org adds report “North America Aesthetic Lasers and Energy Devices Market Outlook to 2020” to its store.

 

“North America Aesthetic Lasers and Energy Devices Market Outlook to 2020″, provides key market data on the North America Aesthetic Lasers and Energy Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG and Diode Lasers), Radio Frequency-Assisted Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted Liposuction (PAL) Devices), Non Invasive Body Contouring Devices (Radiofrequency Energy Devices and High Intensity Focused Ultrasound (HIFU) Devices) and Laser Resurfacing Devices (CO2, Er:YAG and Q-Switched Laser Devices).

 

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Aesthetic Lasers and Energy Devices market wherever available.

 

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

 

Complete report available @ http://www.marketoptimizer.org/north-america-aesthetic-lasers-and-energy-devices-market-outlook-to-2020.html .

 

Overview of Key Companies in North America Aesthetic Lasers and Energy Devices Market

 

Syneron Medical Ltd.Cynosure, Inc.Solta Medical, Inc.Lumenis Ltd.Alma Lasers, Ltd.DEKA Laser Technologies, Inc.Cutera, Inc.Quanta System S.p.AIlooda Co., Ltd.Sciton Inc.

 

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

 

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

 

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9845 .

(This is a premium report priced at US$3000 for a single user PDF.)

 

Scope

 

Market size data for Aesthetic Lasers and Energy Devices market segments Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG and Diode Lasers), Radio Frequency-Assisted Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted Liposuction (PAL) Devices), Non Invasive Body Contouring Devices (Radiofrequency Energy Devices and High Intensity Focused Ultrasound (HIFU) Devices) and Laser Resurfacing Devices (CO2, Er:YAG and Q-Switched Laser Devices).Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.2013 company shares and distribution shares data for Aesthetic Lasers and Energy Devices market.Global corporate-level profiles of key companies operating within the Aesthetic Lasers and Energy Devices market.Key players covered include Syneron Medical, Cynosure, Alma Lasers and Quanta Medical Lasers.

 

Reasons to buy

 

Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.Develop market-entry and market expansion strategies.Design competition strategies by identifying who-stands-where in the market.Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9845 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Research on North America Laparoscopes Industry to 2020

MarketOptimizer.org adds report “North America Laparoscopes Market Outlook to 2020” to its store.

 

“North America Laparoscopes Market Outlook to 2020″, provides key market data on the North America Laparoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Video Laparoscopes (Rigid Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic Surgical Systems and Rigid Tip Non-Video Laparoscopes.

 

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Laparoscopes market wherever available.

 

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

 

Complete report available @ http://www.marketoptimizer.org/north-america-laparoscopes-market-outlook-to-2020.html .

 

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

 

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

 

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

 

Scope

 

Market size data for Laparoscopes market segments Video Laparoscopes (Rigid Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic Surgical Systems and Rigid Tip Non-Video Laparoscopes.Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.2013 company shares and distribution shares data for Laparoscopes market.Global corporate-level profiles of key companies operating within the North America Laparoscopes market.Key players covered include Olympus Corporation, KARL STORZ GmbH & Co. KG, B. Braun Melsungen AG and Intuitive Surgical, Inc.

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9843 .

(This is a premium report priced at US$3000 for a single user PDF.)

 

Reasons to buy

 

Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.Develop market-entry and market expansion strategies.Design competition strategies by identifying who-stands-where in the market.Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

 

Overview of Key Companies in North America Laparoscopes Market

 

Intuitive Surgical, Inc.Olympus CorporationKARL STORZ GmbH & Co. KGRichard Wolf GmbHStryker CorporationB. Braun Melsungen AG

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9843 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

 

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

China Styrene Industry Chain Report, 2014-2017 by Research In China at China Market Research Reports

China Styrene Industry Chain Report, 2014-2017 by Research In China at China Market Research Reports | Business Market Research Reports | Scoop.it
China Styrene Industry Chain Report, 2014-2017 published in Aug 2014 Available for US $ 2250 at ChinaMarketResearchReports.com - Buy Now or Inquire about this report online.
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Coronary Vasospasm Therapeutics Clinical Trials Industry Review Report H2 2014

MarketOptimizer.org adds report “Coronary Vasospasm Global Clinical Trials Review, H2, 2014” to its store.

 

“Coronary Vasospasm Global Clinical Trials Review, H2, 2014″ provides data on the Coronary Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Vasospasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

 

Complete report available @ http://www.marketoptimizer.org/coronary-vasospasm-global-clinical-trials-review-h2-2014.html .

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9801 .

(This is a premium report priced at US$2500 for a single user PDF.)

 

List of Tables

 

Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region, 2014* 6

Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7

Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8

Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9

Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10

Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries, 2014* 11

Coronary Vasospasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12

Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13

Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14

Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15

Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16

Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase, 2014* 17

Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18

Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19

Coronary Vasospasm Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20

Coronary Vasospasm Therapeutics, Global, Suspended Clinical Trials, 2014* 21

Coronary Vasospasm Therapeutics, Global, Withdrawn Clinical Trials, 2014* 21

Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22

Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23

Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24

Coronary Vasospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25

Coronary Vasospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 27

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Coronary Spasm Association, 2014* 28

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert Bosch Medical Center, 2014* 29

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin University, 2014* 30

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014* 31

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Health and Medical Research, 2014* 32

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014* 33

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea University, 2014* 34

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 35

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 36

Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 37

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9801 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Coronary Stenosis Therapeutics Clinical Trials Market Research Report H2 2014

MarketOptimizer.org adds report “Coronary Stenosis Global Clinical Trials Review, H2, 2014” to its store.

 

“Coronary Stenosis Global Clinical Trials Review, H2, 2014″ provides data on the Coronary Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Stenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

 

Complete report available @ http://www.marketoptimizer.org/coronary-stenosis-global-clinical-trials-review-h2-2014.html .

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9799 .

(This is a premium report priced at US$2500 for a single user PDF.)

 

List of Tables

 

Coronary Stenosis Therapeutics, Global, Clinical Trials by Region, 2014* 7

Coronary Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Coronary Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Coronary Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10

Coronary Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11

Coronary Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

Coronary Stenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13

Proportion of Coronary Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14

Coronary Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15

Coronary Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16

Proportion of Coronary Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17

Coronary Stenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18

Coronary Stenosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19

Coronary Stenosis Therapeutics, Global, Clinical Trials by Phase, 2014* 20

Coronary Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21

Coronary Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22

Coronary Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23

Coronary Stenosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24

Coronary Stenosis Therapeutics, Global, Terminated Clinical Trials, 2014* 25

Coronary Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26

Coronary Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27

Coronary Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28

Coronary Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30

Coronary Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 32

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bracco Diagnostics Inc., 2014* 33

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2014* 34

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 35

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by General Electric Company, 2014* 36

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 37

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardio Research Enschede BV, 2014* 38

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 39

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by BioRest Ltd, 2014* 40

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 41

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 42

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 43

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014* 44

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite – Universitatsmedizin Berlin, 2014* 45

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014* 46

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 47

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2014* 48

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2014* 49

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saarland University Hospital, 2014* 50

Coronary Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by St George’s Healthcare NHS Trust., 2014* 51

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9799 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Chagas Cardiomyopathy Therapeutics Clinical Trials Industry H2 2014

MarketOptimizer.org adds report “Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014” to its store.

 

“Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014″ provides data on the Chagas Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chagas Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chagas Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

 

Complete report available @ http://www.marketoptimizer.org/chagas-cardiomyopathy-global-clinical-trials-review-h2-2014.html .

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9797 .

(This is a premium report priced at US$2500 for a single user PDF.)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9797 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Fatty Liver Disease Therapeutics Clinical Trials Market H2 2014

MarketOptimizer.org adds report “Fatty Liver Disease Global Clinical Trials Review, H2, 2014” to its store.

 

“Fatty Liver Disease Global Clinical Trials Review, H2, 2014″ provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fatty Liver Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

 

Complete report available @ http://www.marketoptimizer.org/fatty-liver-disease-global-clinical-trials-review-h2-2014.html .

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9795 .

(This is a premium report priced at US$2500 for a single user PDF.)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9795 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

 

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Biopower Market (Biogas & Biomass) Technology Review, Competitive Landscape and Key Country Analysis to 2020 in a New Report Available at MarketOptimizer.org | Benzinga

Global Biopower Market (Biogas & Biomass) Technology Review, Competitive Landscape and Key Country Analysis to 2020 in a New Report Available at MarketOptimizer.org | Benzinga | Business Market Research Reports | Scoop.it
MarketOptimizer.org adds “Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020” to its store. The ...
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Biopower Market (Biogas & Biomass) Technology Review, Competitive Landscape and Key Country Analysis to 2020 in a New Report Available at MarketOptimizer.org

Global Biopower Market (Biogas & Biomass) Technology Review, Competitive Landscape and Key Country Analysis to 2020 in a New Report Available at MarketOptimizer.org | Business Market Research Reports | Scoop.it
MarketOptimizer.org adds “Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020” to its store. The report provides a clear overview of and detailed insight into the global biopower market.
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Middle East and Africa LNG Terminals Market Outlook - RnR Market Research

Capacity and Capital Expenditure Outlook for LNG Terminals in the Middle East and Africa: Order report by calling marketoptimizer.org at +1 888 391 5441...
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Tullow Oil plc, Company Intelligence Report - RnR Market Research

Tullow Oil plc, Company Intelligence Report: Order report by calling marketoptimizer.org at +1 888 391 5441 OR send an email on sales@marketoptimizer.org...
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Biopower Industry Insights & Analysis to 2020 - RnR Market Research

Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020: Order report by calling marketoptimizer.org at...
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Biopower Industry Insights & Analysis to 2020

Global Biopower Industry Insights & Analysis to 2020 | Business Market Research Reports | Scoop.it
Biopower – Global Market Size, Technology Review, Competitive
Landscape, and Key Country Analysis to 2020:
Order report by calling marketoptimizer.org at...
rnrmarketresearch's insight:

Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020: Order report by calling marketoptimizer.org at +1 888 391 5441 OR send an email on sales@marketoptimizer.org  with Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020 in subject line and your contact details.

“Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020”, the latest report from industry analysis specialist GlobalData, offers comprehensive information and analysis of the global biopower market.

The report provides a clear overview of and detailed insight into the global biopower market. It explains the key drivers and challenges affecting the market and also provides data regarding historic and forecast market growth, average capital expenditure, market size and regulations, globally and in the key biopower countries: US, Brazil, UK, Germany, India, and China.

The report uses data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GlobalData’s team of industry experts.

Scope

Detailed historic and forecast statistics for annual biomass and biogas installations from 2006 to 2025, both globally and for each of the key countriesReview of technology and cost.Coverage of the key growth drivers and challenges related to the global biopower marketCoverage of key countries in the biopower market and details of the share of biopower installations held by eachExplanation of the policies and regulations related to biopower in each of the key countries, and their impact on the market.

 

 Complete report available at http://www.marketoptimizer.org/biopower-global-market-size-technology-review-competitive-landscape-and-key-country-analysis-to-2020.html

Reasons To Buy

Facilitate decision-making based on strong historic and forecast data for the biopower marketMaximize potential in the growth of the biopower marketIdentify key partners and business-development avenuesRespond to competitors’ business structure, strategy and prospects

Table of Contents For This Report

1 Table of Contents 2

2 Executive Summary 11

3 Introduction 14

4 BioPower Market, Global 20

5 BioPower Market, US 40

6 BioPower Market, Brazil 65

7 BioPower Market, UK 79

8 BioPower Market, Germany 92

9 BioPower Market, India 10

10 BioPower Market, China 120

11 Appendix 133

Inquire for discount  @ http://www.marketoptimizer.org/contacts/discount?rname=9942 . (Report price: Single user license- US$ 3995 )

List of Tables

Table 1: Biopower Market, Primary Energy Conversion and Recovery Technologies, Comparison 15

Table 2: Biopower Market, Primary Energy Conversion and Recovery Technologies, Future Developments 18

Table 3: BioPower Market, Global, Cumulative Installed Capacity, GW, 2006–2025 22

Table 4: BioPower Market, Global, Annual Installed Capacity, GW, 2006–2025 24

Table 5: BioPower Market, Global, Annual Installed Capacity Split by country (%), 2013 26

Table 6: BioPower Market, Global, Cumulative Capacity by Feedstock, 2014 & 2019 28

Table 7: BioPower Market, North America, Cumulative Capacity by Feedstock, 2014 & 2019 29

Table 8: BioPower Market, Global, Cumulative Capacity by Feedstock, 2014 31

Table 9: BioPower Market, Global, Cumulative Capacity by Feedstock, 2014 32

Table 10: BioPower Market, Global, Electricity Generation, TWh, 2006–2025 34

Table 11: BioPower Market, Global, Average Capital Expenditure ($/kW), 2011–2025 36

Table 12: BioPower Market, Global, Investment ($bn), 2011–2025 38

Table 13: BioPower Market, US, Cumulative Installed Capacity, GW, 2006–2025 42

Buy a Copy of Report @ http://www.marketoptimizer.org/contacts/purchase?rname=9942 .

Contact sales@marketoptimizer.org   / Call +1 888 391 5441 for further information on “Biopower – Global Market Size, Technology Review, Competitive Landscape, and Key Country Analysis to 2020” report OR for any other market research and intelligence needs you may have for your business.

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

North America Hysteroscopes Industry Forecast to 2020

MarketOptimizer.org adds report “North America Hysteroscopes Market Outlook to 2020” to its store.

 

“North America Hysteroscopes Market Outlook to 2020″, provides key market data on the North America Hysteroscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Flexible Video Hysteroscopes and Non-Video Hysteroscopes (Rigid Non-Video Hysteroscopes and Flexible Non-Video (Fibre) Hysteroscopes).

 

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Hysteroscopes market wherever available.

 

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

 

Complete report available @ http://www.marketoptimizer.org/north-america-hysteroscopes-market-outlook-to-2020.html .

 

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

 

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

 

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

 

Scope

 

Market size data for Hysteroscopes market segments Flexible Video Hysteroscopes and Non-Video Hysteroscopes (Rigid Non-Video Hysteroscopes and Flexible Non-Video (Fibre) Hysteroscopes).Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.2013 company shares and distribution shares data for Hysteroscopes market.Global corporate-level profiles of key companies operating within the North America Hysteroscopes market.Key players covered include Olympus Corporation, Hoya Corporation, Fujifilm Holdings Corporation and KARL STORZ GmbH & Co. KG.

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9844 .

(This is a premium report priced at US$3000 for a single user PDF.)

 

Reasons to buy

 

Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.Develop market-entry and market expansion strategies.Design competition strategies by identifying who-stands-where in the market.Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

 

Overview of Key Companies in North America Hysteroscopes Market

 

KARL STORZ GmbH & Co. KGOlympus CorporationStryker CorporationRichard Wolf GmbH

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9844 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

2020 Canada Aesthetic Lasers and Energy Devices Market Overview

MarketOptimizer.org adds report “Canada Aesthetic Lasers and Energy Devices Market Outlook to 2020” to its store.

 

“Canada Aesthetic Lasers and Energy Devices Market Outlook to 2020″, provides key market data on the Canada Aesthetic Lasers and Energy Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG and Diode Lasers), Radio Frequency-Assisted Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted Liposuction (PAL) Devices), Non Invasive Body Contouring Devices (Radiofrequency Energy Devices and High Intensity Focused Ultrasound (HIFU) Devices) and Laser Resurfacing Devices (CO2, Er:YAG and Q-Switched Laser Devices).

 

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Aesthetic Lasers and Energy Devices market wherever available.

 

Complete report available @ http://www.marketoptimizer.org/canada-aesthetic-lasers-and-energy-devices-market-outlook-to-2020.html .

 

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

 

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

 

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

 

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

 

Overview of Key Companies in Canada, Aesthetic Lasers and Energy Devices Market

 

Syneron Medical Ltd.Cynosure, Inc.Solta Medical, Inc.Lumenis Ltd.Alma Lasers, Ltd.DEKA Laser Technologies, Inc. (DEKA)Cutera, Inc.Quanta System S.p.ASciton Inc.

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9835 .

(This is a premium report priced at US$2500 for a single user PDF.)

 

Scope

 

Market size data for Aesthetic Lasers and Energy Devices market segments Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG and Diode Lasers), Radio Frequency-Assisted Liposuction (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted Liposuction (PAL) Devices), Non Invasive Body Contouring Devices (Radiofrequency Energy Devices and High Intensity Focused Ultrasound (HIFU) Devices) and Laser Resurfacing Devices (CO2, Er:YAG and Q-Switched Laser Devices).Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.2013 company shares and distribution shares data for Aesthetic Lasers and Energy Devices market.Global corporate-level profiles of key companies operating within the Aesthetic Lasers and Energy Devices market.Key players covered include Syneron Medical, Cynosure, Alma Lasers and Quanta Medical Lasers.

 

Reasons to buy

 

Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.Develop market-entry and market expansion strategies.Design competition strategies by identifying who-stands-where in the market.Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9835 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Critical Limb Ischemia Therapeutics Clinical Trials Industry Research Report H2 2014

MarketOptimizer.org adds report “Critical Limb Ischemia Global Clinical Trials Review, H2, 2014” to its store.

 

“Critical Limb Ischemia Global Clinical Trials Review, H2, 2014″ provides data on the Critical Limb Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Critical Limb Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Critical Limb Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

 

Complete report available @ http://www.marketoptimizer.org/critical-limb-ischemia-global-clinical-trials-review-h2-2014.html .

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9802 .

(This is a premium report priced at US$2500 for a single user PDF.)

 

List of Tables

 

Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region, 2014* 7

Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10

Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11

Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13

Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14

Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15

Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16

Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18

Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19

Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21

Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24

Critical Limb Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25

Critical Limb Ischemia Therapeutics, Global, Terminated Clinical Trials, 2014* 26

Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28

Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29

Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31

Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2014* 33

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2014* 34

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 35

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014* 36

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stempeutics Research Private Limited, 2014* 37

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ReNeuron Group plc, 2014* 38

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2014* 39

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medistem, Inc., 2014* 40

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by GWT-TUD GmbH, 2014* 41

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2014* 42

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Progreso y Salud, 2014* 43

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 44

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts University, 2014* 45

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 46

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Rosai Hospital, 2014* 47

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation Hospital, 2014* 48

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 49

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by CHU de Reims, 2014* 50

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bern, 2014* 51

Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2014* 52

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9802 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Coronary Thrombosis Therapeutics Clinical Trials Market Review Report H2 2014

MarketOptimizer.org adds report “Coronary Stenosis Global Clinical Trials Review, H2, 2014” to its store.

 

“Coronary Thrombosis Global Clinical Trials Review, H2, 2014″ provides data on the Coronary Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

 

Complete report available @ http://www.marketoptimizer.org/coronary-thrombosis-global-clinical-trials-review-h2-2014.html .

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9800 .

(This is a premium report priced at US$2500 for a single user PDF.)

 

List of Tables

 

Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014* 6

Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7

Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8

Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9

Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10

Coronary Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11

Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12

Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13

Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14

Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15

Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014* 16

Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17

Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18

Coronary Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19

Coronary Thrombosis Therapeutics, Global, Terminated Clinical Trials, 2014* 20

Coronary Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21

Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22

Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital de la Timone, 2014* 24

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fujian Provincial Hospital, 2014* 25

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Herz-Zentrum Bad Krozingen, 2014* 26

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014* 27

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Greater Glasgow and Clyde, 2014* 28

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 29

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014* 30

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014* 31

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2014* 32

Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique – Hopitaux de Paris, 2014* 33

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9800 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Coronary Arteriosclerosis Therapeutics Clinical Trials Industry Research H2 2014

MarketOptimizer.org adds report “Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014” to its store.

 

“Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014″ provides data on the Coronary Arteriosclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Arteriosclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Arteriosclerosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

 

Complete report available @ http://www.marketoptimizer.org/coronary-arteriosclerosis-global-clinical-trials-review-h2-2014.html .

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9798 .

(This is a premium report priced at US$2500 for a single user PDF.)

 

List of Tables

 

Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region, 2014* 7

Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10

Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11

Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13

Coronary Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14

Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15

Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16

Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18

Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19

Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21

Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24

Coronary Arteriosclerosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25

Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26

Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27

Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28

Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29

Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 31

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 32

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 33

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2014* 34

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 35

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 36

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by MDDX LLC, 2014* 37

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovaderm Research Inc., 2014* 38

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CardioVascular BioTherapeutics, Inc., 2014* 39

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Avant Immunotherapeutics, Inc, 2014* 40

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 41

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Providence VA Medical Center, 2014* 42

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 43

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 44

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 45

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014* 46

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 47

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2014* 48

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 49

Coronary Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 50

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9798 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Sickle Cell Disease Therapeutics Clinical Trials Market Analysis H2 2014

MarketOptimizer.org adds report “Sickle Cell Disease Global Clinical Trials Review, H2, 2014” to its store.

 

“Sickle Cell Disease Global Clinical Trials Review, H2, 2014″ provides data on the Sickle Cell Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sickle Cell Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sickle Cell Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

 

Complete report available @ http://www.marketoptimizer.org/sickle-cell-disease-global-clinical-trials-review-h2-2014.html .

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nationsClinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor typeListings of discontinued trials (suspended, withdrawn and terminated)

 

Inquire before Buying @ http://www.marketoptimizer.org/contacts/inquire-before-buying?rname=9796 .

(This is a premium report priced at US$2500 for a single user PDF.)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed mannerAbridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many moreObtain discontinued trial listing for trials across the globeEspy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

Purchase a copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=9796 .

 

About Us:

MarketOptimizer.org is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.